pyrrolidine dithiocarbamate has been researched along with Ache in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves-Filho, JC; Borghi, SM; Carvalho, TT; Casagrande, R; Cunha, FQ; Cunha, TM; Fattori, V; Pinho-Ribeiro, FA; Staurengo-Ferrari, L; Verri, WA; Zarpelon, AC | 1 |
Guo, Q; Pan, Y; Peng, B; Wang, P; Zou, W | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and Ache
Article | Year |
---|---|
Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress.
Topics: Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Edema; Inflammation; Male; Mice; NF-kappa B; Oxidative Stress; Pain; Pyrrolidines; Spinal Cord; Superoxides; Thiocarbamates | 2016 |
[Regulation of inflammatory pain by NF-κB and CX3CR1 at the spinal cord of rats].
Topics: Animals; Arthritis; CX3C Chemokine Receptor 1; Injections, Spinal; Male; NF-kappa B; Pain; Pain Threshold; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Spinal Cord; Thiocarbamates | 2010 |